Skip to content

Comparison of intra-articular injection of triamcinolone acetonide combined with ropivacaine and ropivacaine alone in relieving pain and reducing inflammation response after shoulder arthroscopy: a prospective randomized study

Comparison of intra-articular injection of triamcinolone acetonide combined with ropivacaine and ropivacaine alone in relieving pain and reducing inflammation response after shoulder arthroscopy: a prospective randomized study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042366
Enrollment
Unknown
Registered
2021-01-21
Start date
2021-01-18
Completion date
Unknown
Last updated
2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of shoulder arthroscopic surgery

Interventions

control group:local intra-articular injection of 10mg ropivacaine
experimental group:local intra-articular injection of 10mg ropivacaine + 40mg triamcinolone acetonide

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The American Society of Anesthesiologists classified as grade I-II, regardless of gender, aged 18-65 years old, patients underwent shoulder arthroscopy under general anesthesia, the surgery mainly involved shoulder joint exploration, joint synovectomy and acromioplasty.

Exclusion criteria

Exclusion criteria: History of perioperative drug allergy in the past, serious chronic diseases that affected normal postoperative recovery, other diseases that affected inflammatory indicators such as rheumatoid diseases or infections.

Design outcomes

Primary

MeasureTime frame
visual analogue scale;C-reactive protein;erythrocyte sedimentation rate;

Countries

China

Contacts

Public ContactLi Zhang

Qilu Hospital of Shandong University

qlyygjwk@163.com+86 18560082618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026